Tramadol Addiction: How a Legal Painkiller Becomes Dependency

Tramadol dependency almost always starts with a legitimate prescription for real pain, which is exactly why it goes unnoticed for so long. Unlike codeine or morphine, tramadol works through two separate mechanisms — a weak opioid effect and serotonin/noradrenaline reuptake inhibition — giving it unique risks including seizures and serotonin syndrome, and making unsupervised withdrawal genuinely dangerous. Holina Rehab treats tramadol addiction with medically supervised detox built around these specific risks, alongside trauma-informed therapy and two years of aftercare.

It usually starts with a straightforward sentence from a doctor: take one or two tablets, up to four times a day, for the pain. There is a prescription, a pharmacy label, a legitimate reason. For many people, that is where it ends — the course finishes, the tablets go back in the cabinet or down the sink. For others, something quieter happens in between: the tablets keep feeling necessary long after the original injury has settled, and stopping starts to feel not just unpleasant but unsafe. Nobody sets out to become dependent on a medicine their GP prescribed for a bad back or a wisdom tooth extraction. That is precisely how tramadol dependency tends to begin.

For the family member watching this unfold, the confusion can be harder still to place. There was no dealer, no obvious moment where things went wrong — just a repeat prescription, a pharmacy visit that became a little too routine, and a person who seems anxious or unwell whenever a dose is due. How does a painkiller from a pharmacy become this? It is a fair question, and it deserves a real answer rather than reassurance.

The honest answer is that tramadol is not simply “a weaker opioid,” and treating it as one is exactly why so many cases of dependency go unnoticed for so long. Pharmacologically, tramadol behaves differently from codeine and morphine, carrying distinct risks — including seizures and serotonin syndrome — that those other opioids do not typically produce. Understanding that difference is the starting point for treating tramadol dependency seriously in its own right, with an addiction-first approach delivered under genuine medical supervision, which is exactly how Holina Rehab treats it.

What Makes Tramadol Different From Other Opioids?

Most people, including many prescribers, think of tramadol as sitting on the same spectrum as codeine — just a notch stronger. Pharmacologically, that framing misses what makes tramadol unusual. It works through two mechanisms at once. The first is a relatively weak action at the mu-opioid receptor, and even that depends heavily on the drug being converted by the liver enzyme CYP2D6 into a more active metabolite known as M1, as detailed in DrugBank’s pharmacology entry. The second mechanism has nothing to do with opioid receptors: tramadol also inhibits the reuptake of serotonin and noradrenaline in the brain — the same broad mechanism found in SNRI antidepressants such as venlafaxine, not in codeine or morphine.

According to the World Federation of Societies of Anaesthesiologists’ clinical and pharmacologic review of tramadol and tapentadol, tramadol is sold as a mixture of two mirror-image molecules, or enantiomers, that work synergistically: one preferentially inhibits serotonin reuptake, the other noradrenaline reuptake. That dual identity — part weak opioid, part serotonin-noradrenaline reuptake inhibitor — is the root of everything that makes tramadol clinically distinctive, including risks that codeine and morphine simply do not carry to the same degree: seizures and serotonin syndrome.

The UK’s regulators took this seriously enough to act on it. Under the Misuse of Drugs and Misuse of Drugs (Safe Custody) (Amendment) (England, Wales and Scotland) Regulations 2014 (SI 2014/1275), tramadol was reclassified as a Schedule 3 controlled drug with effect from 10 June 2014 — a change reported at the time by MIMS UK in “Tramadol reclassified as a controlled drug” — specifically in response to rising misuse and tramadol-related deaths. A medicine does not get moved into a more tightly controlled legal category for no reason.

Why Is Tramadol Addiction So Often Missed or Underestimated?

Tramadol is prescribed constantly, and for entirely ordinary reasons: chronic back pain, dental procedures, post-surgical recovery, arthritis flare-ups. It is a medicine associated with everyday pain rather than dramatic medical crisis — which is exactly why patients, families, and sometimes even clinicians don’t watch it with the wariness they’d apply to morphine or oxycodone.

The scale of that prescribing tells its own story. Jani and colleagues, writing in PLOS Medicine in 2020 in their retrospective cohort study “Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain”, found that tramadol prescriptions in UK primary care rose roughly seven-fold between 2006 and 2017 — climbing steeply from 2006 to 2012 before levelling off. That is not a niche medicine; it quietly became a routine feature of British pain management within a single decade.

Clinically, tramadol was never meant to be a first port of call. NICE guideline NG193 on chronic pain assessment and management is explicit that opioids, tramadol included, should not be initiated for chronic primary pain, and that tramadol is positioned as an option only where first-line weak opioids — codeine or co-codamol — have already failed or aren’t tolerated. NICE also flags a maximum daily dose of 400mg in 24 hours as a safety-critical instruction. Tramadol is designed as a step along a pathway, not an endpoint — yet many patients remain on it for months or years past the point their original pain has resolved.

The point worth sitting with: “weaker opioid” describes potency and dosing, not safety. Tramadol’s distinctive risks — seizure and serotonin syndrome — are not shared, dose-for-dose, by codeine. A medicine can be less potent as a painkiller and still carry risks that are, in their own way, more dangerous.

What Are the Unique Risks of Tramadol — Seizures and Serotonin Syndrome?

This is the section that separates tramadol from every other commonly prescribed opioid.

Seizure risk. Tramadol carries a seizure risk that classic opioids like codeine and morphine simply do not share, and — critically — this risk is not confined to overdose or misuse. Park, Wackernah and Stimmel, writing in The American Journal of Medicine in 2018 in “Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures,” document that seizures can occur even at recommended therapeutic doses, with risk rising sharply at higher doses, with misuse, and when tramadol is combined with other substances that lower the seizure threshold. A 2020 systematic review and meta-analysis (PubMed ID 31914355) reinforces the same conclusion: this is a recognised pharmacological risk, not a rare idiosyncratic reaction.

Serotonin syndrome. Because tramadol inhibits serotonin reuptake, combining it with other serotonergic medicines — SSRIs, SNRIs, tricyclic antidepressants, or MAOIs — meaningfully raises the risk of serotonin syndrome: a potentially life-threatening combination of cognitive changes (agitation, confusion), neuromuscular symptoms (tremor, rigidity, clonus), and autonomic instability (rapid heart rate, high blood pressure, fever). This is precisely the risk codeine and morphine do not carry, because neither touches serotonin at all. UK-approved prescribing information — the BNF entry and the Summary of Product Characteristics for tramadol — carries explicit cautions against co-prescribing with serotonergic agents, and the peer-reviewed literature above sets out the clinical mechanism in detail.

The real-world data is sobering. Research published in Innovations in Clinical Neuroscience, “Tramadol: Seizures, Serotonin Syndrome, and Coadministered Antidepressants,” found that in seizure cases linked to tramadol use, close to half involved a concomitant drug — more than half of those specifically antidepressants, including SSRIs, tricyclics, venlafaxine, and bupropion. A 2024/2025 cohort study in Neurology, “Risk of Seizure Associated With Concomitant Use of Tramadol and Antidepressants in Older Nursing Home Residents,” confirms the same interaction risk in a vulnerable population prescribed both together.

Tramadol’s interaction profile isn’t limited to serotonergic drugs alone. The MHRA has separately issued a Drug Safety Update flagging the tramadol-warfarin interaction, which raises bleeding risk — evidence of an unusually interaction-heavy risk profile for a medicine still widely perceived as “mild.” (To be precise: this MHRA update concerns the warfarin interaction, not the SSRI/serotonin syndrome risk described above — that risk is documented in BNF/SmPC prescribing cautions and the peer-reviewed sources cited here, not a named MHRA bulletin.)

Taken together, this is why unsupervised, self-directed withdrawal from tramadol is genuinely dangerous, and why detox needs close medical supervision — because tramadol’s seizure risk is a specific, documented clinical reality during discontinuation.

How Common Is Tramadol Dependency in the UK, and Who’s Affected?

This is not a fringe issue. Tramadol remains, by the NHS Business Services Authority’s own English Prescribing Dataset — tracked publicly via OpenPrescribing under BNF code 040702040 (Tramadol hydrochloride) — one of the most frequently dispensed opioid analgesics in England’s primary care. NHS England has gone as far as flagging paracetamol/tramadol combination products specifically on its “low priority” prescribing list, a clear institutional signal of concern about the volume and appropriateness of tramadol prescribing in routine general practice.

The mortality data tells a more sobering story. According to the Office for National Statistics’ ongoing “Deaths related to drug poisoning in England and Wales” bulletins, tramadol-involved deaths rose from 83 in 2008 to 175 in 2012, before peaking at 240 in 2014 — the very same year tramadol was reclassified as a Schedule 3 controlled drug — and stood at 223 in 2022. For wider context, the ONS’s “Deaths related to drug poisoning in England and Wales: 2023 registrations” bulletin recorded 5,448 total drug-poisoning deaths across England and Wales in 2023, the highest figure since comparable records began in 1993.

Put those two data points together and the picture is unambiguous: this is a medicine prescribed by GPs, collected from pharmacies, and taken as directed by ordinary people managing ordinary pain — and it is, measurably and trackably, causing deaths every year. It is not a street drug problem; it is a prescribing and dependency problem happening inside the NHS system itself, which is exactly why families shouldn’t wait for a crisis that looks like “classic” addiction before taking tramadol dependency seriously.

What Does Tramadol Withdrawal Actually Involve?

Because tramadol affects serotonin and noradrenaline systems alongside opioid receptors, its withdrawal picture doesn’t match a textbook opioid detox. Alongside the standard physical symptoms familiar from any opioid withdrawal — muscle aches, sweating, insomnia, gastrointestinal distress — people withdrawing from tramadol can also experience an atypical, SNRI-type discontinuation pattern: heightened anxiety, mood disturbance, and sensory disturbances such as tingling or “brain zap” sensations not typically seen in codeine or morphine withdrawal. NICE’s NG193 guidance notes that withdrawal symptoms with tramadol can occur even after relatively short courses of use.

The seizure risk covered above applies here with particular force. Abrupt discontinuation after a period of regular tramadol use — especially at higher doses — carries a genuine seizure risk during withdrawal itself, documented in the same literature already cited (Park et al., 2018; the 2020 seizure systematic review). This is the clinical reason a self-directed “cold turkey” approach is a real danger with tramadol in a way it isn’t, to the same degree, with codeine — and exactly why medically supervised detox is a necessity built around a specific, documented risk, not a precaution taken for form’s sake.

How Holina Rehab Treats Tramadol Addiction

Because tramadol dependency so often begins with a legitimate prescription for real pain, effective treatment has to hold two truths at once: treating the addiction itself, and not simply abandoning someone to unmanaged pain in the process. That’s the foundation of Holina’s approach — addiction-first, not detox-first, care that treats the whole person rather than the substance in isolation, delivered by our clinical team.

Medically supervised detox sits at the centre of that approach, and with tramadol specifically, seizure risk during withdrawal is a genuine clinical consideration built directly into our protocols. Our medical team monitors and manages this risk deliberately, rather than applying a generic opioid-taper template that assumes tramadol behaves like codeine or morphine — it doesn’t. Where medication-assisted treatment is clinically appropriate, our Suboxone vs Naltrexone vs Methadone comparison explains how each option is weighed, applied judiciously given tramadol’s own serotonergic profile to avoid compounding interaction risk.

Alongside detox, our clinical model draws on NARM (NeuroAffective Relational Model) and Somatic Therapy, addressing the nervous-system and trauma dimensions that so often sit underneath chronic pain — and, in turn, underneath the dependency that followed it. Hyperbaric oxygen therapy (HBOT) is offered as a supportive modality. This whole-person approach is formalised in our Dual Treatment programme, which addresses addiction and co-occurring behavioural health difficulties together.

Family therapy is a core part of treatment, not an afterthought — because the family members who watched this dependency develop, often with real confusion about how it happened, deserve to be part of supporting recovery. Our programme also integrates mindfulness and Buddhist-influenced practices, set within the context of our Thailand facility.

We describe co-occurring addiction and psychological difficulties as behavioural health and dual treatment — never mental health or dual diagnosis. And recovery doesn’t end at discharge: Thrucare, our two-year aftercare programme, reflects a long-horizon commitment appropriate to a dependency that, for many clients, began years earlier as ordinary pain management rather than a single dramatic event.

Holina Rehab is a private, internationally licensed facility, working specifically with clients from the UK, Australia, and Canada who are seeking a confidential, medically supervised path away from tramadol dependency and back toward genuine pain management and recovery.

What Families Can Do Now

If someone you love is dependent on tramadol, timing and tone matter. Avoid raising it in a crisis moment; instead, choose a calm point to talk, grounding the conversation in specific, factual risks — seizure risk, serotonin syndrome, drug interactions — rather than framing it as “you’re addicted,” which tends to trigger defensiveness rather than openness.

Do not help or encourage abrupt, self-directed withdrawal. The seizure risk covered earlier is real and is precisely why “just stopping” is not a safe home strategy with tramadol, even with the best intentions. Raise this as a reason to seek medical supervision, not as a reason to avoid the conversation altogether.

Pay attention to one specific combination: is your family member also taking an antidepressant? That combination — tramadol alongside an SSRI, SNRI, or tricyclic — is worth raising directly with a GP or addiction specialist.

Encourage a conversation with the prescribing GP about a structured tapering plan, rather than unilateral cessation. And when you’re ready, speak with our admissions team for a confidential family consultation to talk through what treatment could look like — with no obligation, and no judgement about how long it’s taken to get here.

Frequently asked questions

Is tramadol as addictive as other opioids?

Its opioid effect is comparatively weak, but “weaker” describes potency, not safety. Tramadol’s dual mechanism — mild opioid activity plus serotonin/noradrenaline reuptake inhibition — carries dependency risk alongside dangers, including seizures and serotonin syndrome, that codeine and morphine don’t share.

Can you become dependent on tramadol even if you take it exactly as prescribed?

Yes. Dependency can develop with prescribed, on-label use, particularly with longer courses. NICE guideline NG193 notes withdrawal symptoms can occur even after relatively short periods of use.

What’s the difference between tramadol addiction and codeine addiction?

Codeine works solely on opioid receptors. Tramadol combines a weak opioid effect with serotonin and noradrenaline reuptake inhibition — the mechanism found in SNRI antidepressants. That’s why tramadol carries seizure and serotonin syndrome risk that codeine does not. See our Codeine Addiction Treatment guide for the full comparison.

Why does tramadol cause seizures when other opioids don’t (or less commonly)?

Its serotonergic and noradrenergic activity lowers the seizure threshold in a way classic opioids like codeine and morphine do not. Park et al. (2018) and a 2020 systematic review both document seizures at recommended doses, with risk rising with higher doses, misuse, and co-administered drugs that further lower seizure threshold.

What is serotonin syndrome, and why is it a specific tramadol risk?

A potentially life-threatening reaction caused by excess serotonin activity, presenting with cognitive, neuromuscular, and autonomic symptoms. Because tramadol inhibits serotonin reuptake, combining it with SSRIs, SNRIs, tricyclics, or MAOIs raises this risk — a mechanism that doesn’t apply to codeine or morphine.

Is it safe to take tramadol with antidepressants?

Not without close medical supervision. UK prescribing information (BNF/SmPC) cautions against combining tramadol with serotonergic antidepressants, and research in Innovations in Clinical Neuroscience and a Neurology cohort study links this combination to elevated seizure and serotonin syndrome risk.

How long does tramadol withdrawal last?

It varies by dose and duration of use, but tramadol withdrawal often combines standard opioid symptoms (aches, sweating, insomnia) with atypical SNRI-type symptoms — anxiety, mood disturbance, sensory disturbances — that can extend beyond a typical codeine or morphine taper.

Can you stop taking tramadol suddenly?

Not recommended. Abrupt discontinuation, particularly after regular use at higher doses, carries a documented seizure risk. Any reduction should happen under medical supervision with a structured tapering plan.

Is tramadol a controlled drug in the UK?

Yes. Tramadol was reclassified as a Schedule 3 controlled drug under SI 2014/1275, effective 10 June 2014, in response to rising misuse and tramadol-related deaths.

How does Holina Rehab treat tramadol addiction differently from a standard opioid detox programme?

Our protocols account for tramadol’s seizure risk during withdrawal rather than a generic opioid-taper template, and medication-assisted treatment is used judiciously given tramadol’s serotonergic profile. Treatment combines medically supervised detox with NARM and Somatic Therapy, HBOT, family therapy, and Thrucare, our two-year aftercare programme.

Clinically reviewed by Dr. Natalie Lindemann — Clinical Director, Holina Global · Last reviewed 18 August 2026.